Log in

NYSE:WST - West Pharmaceutical Services Stock Price, Forecast & News

$173.22
-1.35 (-0.77 %)
(As of 02/19/2020 09:04 AM ET)
Today's Range
$173.00
Now: $173.22
$175.19
50-Day Range
$149.74
MA: $158.22
$174.57
52-Week Range
$101.15
Now: $173.22
$175.21
Volume477,939 shs
Average Volume375,522 shs
Market Capitalization$12.82 billion
P/E Ratio54.13
Dividend Yield0.37%
Beta1.21
West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, South Korea, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, and washing and sterilization processes and services to enhance the quality of packaging components. Read More…

Industry, Sector and Symbol

Industry Fabricated rubber products, not elsewhere classified
Sub-IndustryHealth Care Supplies
SectorMedical
CUSIP95530610
Phone610-594-2900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.84 billion
Cash Flow$4.24 per share
Book Value$18.85 per share

Profitability

Net Income$241.70 million

Miscellaneous

Employees7,700
Market Cap$12.82 billion
Next Earnings Date4/23/2020 (Estimated)
OptionableOptionable

Receive WST News and Ratings via Email

Sign-up to receive the latest news and ratings for WST and its competitors with MarketBeat's FREE daily newsletter.


West Pharmaceutical Services (NYSE:WST) Frequently Asked Questions

What is West Pharmaceutical Services' stock symbol?

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services announced a quarterly dividend on Tuesday, December 17th. Shareholders of record on Wednesday, January 22nd will be paid a dividend of $0.16 per share on Wednesday, February 5th. This represents a $0.64 dividend on an annualized basis and a yield of 0.37%. The ex-dividend date is Tuesday, January 21st. This is a boost from West Pharmaceutical Services's previous quarterly dividend of $0.15. View West Pharmaceutical Services' Dividend History.

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services Inc. (NYSE:WST) released its earnings results on Thursday, February, 13th. The medical instruments supplier reported $0.82 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.72 by $0.10. The medical instruments supplier had revenue of $470.60 million for the quarter, compared to analysts' expectations of $451.53 million. West Pharmaceutical Services had a return on equity of 17.06% and a net margin of 13.14%. The company's quarterly revenue was up 11.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.73 earnings per share. View West Pharmaceutical Services' Earnings History.

When is West Pharmaceutical Services' next earnings date?

West Pharmaceutical Services is scheduled to release their next quarterly earnings announcement on Thursday, April 23rd 2020. View Earnings Estimates for West Pharmaceutical Services.

What guidance has West Pharmaceutical Services issued on next quarter's earnings?

West Pharmaceutical Services issued an update on its FY20 earnings guidance on Thursday, February, 13th. The company provided earnings per share (EPS) guidance of $3.45-3.55 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.40. The company issued revenue guidance of $1.95-1.97 billion, compared to the consensus revenue estimate of $1.95 billion.

What price target have analysts set for WST?

3 analysts have issued 1 year price targets for West Pharmaceutical Services' stock. Their forecasts range from $112.16 to $135.00. On average, they expect West Pharmaceutical Services' stock price to reach $123.05 in the next year. This suggests that the stock has a possible downside of 29.0%. View Analyst Price Targets for West Pharmaceutical Services.

What is the consensus analysts' recommendation for West Pharmaceutical Services?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for West Pharmaceutical Services.

Has West Pharmaceutical Services been receiving favorable news coverage?

News articles about WST stock have trended very negative on Wednesday, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. West Pharmaceutical Services earned a news impact score of -3.7 on InfoTrie's scale. They also assigned news stories about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for West Pharmaceutical Services.

Are investors shorting West Pharmaceutical Services?

West Pharmaceutical Services saw a decline in short interest in January. As of January 31st, there was short interest totalling 1,020,000 shares, a decline of 23.9% from the January 15th total of 1,340,000 shares. Based on an average daily volume of 452,100 shares, the short-interest ratio is presently 2.3 days. Approximately 1.4% of the company's shares are sold short. View West Pharmaceutical Services' Current Options Chain.

Who are some of West Pharmaceutical Services' key competitors?

What other stocks do shareholders of West Pharmaceutical Services own?

Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include PepsiCo (PEP), Johnson & Johnson (JNJ), Mcdonald's (MCD), AbbVie (ABBV), Lowe's Companies (LOW), Medtronic (MDT), Walmart (WMT), NVIDIA (NVDA), AFLAC (AFL) and PPG Industries (PPG).

Who are West Pharmaceutical Services' key executives?

West Pharmaceutical Services' management team includes the folowing people:
  • Mr. Eric M. Green, CEO, Pres & Director (Age 49)
  • Mr. David A. Montecalvo, Sr. VP and Chief Operations & Supply Chain Officer (Age 54)
  • Mr. George Lloyd Miller, Sr. VP, Gen. Counsel & Corp. Sec. (Age 64)
  • Ms. Karen A. Flynn, Chief Commercial Officer & Sr. VP (Age 56)
  • Mr. William J. Federici, Advisor (Age 59)

Who are West Pharmaceutical Services' major shareholders?

West Pharmaceutical Services' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Franklin Resources Inc. (6.01%), State Street Corp (3.70%), Bamco Inc. NY (2.01%), Capital Research Global Investors (1.94%), WCM Investment Management LLC (1.81%) and Artisan Partners Limited Partnership (1.49%). Company insiders that own West Pharmaceutical Services stock include Daniel Malone, Karen Flynn, Patrick J Zenner and William J Federici. View Institutional Ownership Trends for West Pharmaceutical Services.

Which institutional investors are selling West Pharmaceutical Services stock?

WST stock was sold by a variety of institutional investors in the last quarter, including Bessemer Group Inc., Bamco Inc. NY, Cubist Systematic Strategies LLC, Schroder Investment Management Group, Victory Capital Management Inc., Victory Capital Management Inc., USS Investment Management Ltd and Intermede Investment Partners Ltd. View Insider Buying and Selling for West Pharmaceutical Services.

Which institutional investors are buying West Pharmaceutical Services stock?

WST stock was purchased by a variety of institutional investors in the last quarter, including State Street Corp, AJO LP, Sumitomo Mitsui Trust Holdings Inc., Renaissance Technologies LLC, Alliancebernstein L.P., Bank of Montreal Can, Swiss National Bank and Point72 Asset Management L.P.. View Insider Buying and Selling for West Pharmaceutical Services.

How do I buy shares of West Pharmaceutical Services?

Shares of WST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is West Pharmaceutical Services' stock price today?

One share of WST stock can currently be purchased for approximately $173.22.

How big of a company is West Pharmaceutical Services?

West Pharmaceutical Services has a market capitalization of $12.82 billion and generates $1.84 billion in revenue each year. The medical instruments supplier earns $241.70 million in net income (profit) each year or $3.24 on an earnings per share basis. West Pharmaceutical Services employs 7,700 workers across the globe.View Additional Information About West Pharmaceutical Services.

What is West Pharmaceutical Services' official website?

The official website for West Pharmaceutical Services is http://www.westpharma.com/.

How can I contact West Pharmaceutical Services?

West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The medical instruments supplier can be reached via phone at 610-594-2900 or via email at [email protected]


MarketBeat Community Rating for West Pharmaceutical Services (NYSE WST)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  227 (Vote Outperform)
Underperform Votes:  359 (Vote Underperform)
Total Votes:  586
MarketBeat's community ratings are surveys of what our community members think about West Pharmaceutical Services and other stocks. Vote "Outperform" if you believe WST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WST will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel